Creo Medical Group Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	4.6	4	4	27.2	25.16	9.43
Revenue	4.6	4	4	27.2	25.16	9.43
Revenue Growth (YoY)	-	-	-85.29%	8.10%	166.85%	69884.41%
Cost of Revenue	2.5	2.1	1.7	14	13.58	5.39
Gross Profit	2.1	1.9	2.3	13.2	11.59	4.04
Selling, General & Admin	24.7	29.2	29.1	44	41.54	27.57
Other Operating Expenses	0.4	0.4	-0.4	-0.1	-0.05	-0.05
Operating Expenses	25.1	29.6	28.7	43.9	41.49	27.52
Operating Income	-23	-27.7	-26.4	-30.7	-29.91	-23.48
Interest Expense	-0.4	-0.4	-0.2	-0.2	-0.21	-0.07
Interest & Investment Income	0.4	0.2	0.7	0.1	0.03	0.18
Other Non Operating Income (Expenses)	-	-	-	-0.1	-0.25	-0.09
EBT Excluding Unusual Items	-23.3	-27.9	-25.9	-30.9	-30.34	-23.46
Merger & Restructuring Charges	-1.1	-1.1	-	-	-	-
Other Unusual Items	0.1	-	-0.5	-	-	-
Pretax Income	1.9	-29	-26.4	-30.9	-30.34	-23.46
Income Tax Expense	-0.7	-1.2	-2.7	-4	-5.74	-3.15
Earnings From Continuing Operations	2.6	-27.8	-23.7	-26.9	-24.6	-20.32
Earnings From Discontinued Operations	-2.1	-0.9	2	-	-	-
Net Income	0.5	-28.7	-21.7	-26.9	-24.6	-20.32
Net Income to Common	0.5	-28.7	-21.7	-26.9	-24.6	-20.32
Shares Outstanding (Basic)	396	370	313	181	164	156
Shares Outstanding (Diluted)	397	370	313	181	164	156
Shares Change (YoY)	17.86%	18.20%	72.61%	10.28%	5.54%	28.39%
EPS (Basic)	0.00	-0.08	-0.07	-0.15	-0.15	-0.13
EPS (Diluted)	-0.00	-0.08	-0.07	-0.15	-0.15	-0.13
Free Cash Flow	7	-22.5	-22.8	-28.1	-31.99	-16.77
Free Cash Flow Per Share	0.02	-0.06	-0.07	-0.15	-0.20	-0.11
Gross Margin	45.65%	47.50%	57.50%	48.53%	46.04%	42.79%
Operating Margin	-500.00%	-692.50%	-660.00%	-112.87%	-118.86%	-249.06%
Profit Margin	10.87%	-717.50%	-542.50%	-98.90%	-97.75%	-215.46%
Free Cash Flow Margin	152.17%	-562.50%	-570.00%	-103.31%	-127.13%	-177.80%
EBITDA	-23.3	-26.7	-24.7	-28.5	-28.15	-22.49
EBITDA Margin	-	-	-	-104.78%	-111.88%	-238.54%
D&A For EBITDA	-0.3	1	1.7	2.2	1.76	0.99
EBIT	-23	-27.7	-26.4	-30.7	-29.91	-23.48
EBIT Margin	-	-	-	-112.87%	-118.86%	-249.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.